TARGT Absolute is a Comprehensive genomic profiling test that assesses the entire coding region based on DNA & RNA analysis of ~20,000 genes.
TARGT Absolute identifies four major categories of genomic alterations known for tumorigenesis and metastasis: SNVs/InDels, Copy Number Alterations (CNAs), and Gene Fusions/Splice Variants.
TARGT Absolute also provides insights on Immunotherapy Biomarkers: PD-L1 by conventional IHC method, Genomic Signatures; Tumor Mutational Burden (TMB) and Microsatellite Instability (MSI) by NGS method.
TARGT Absolute provides information on true Somatic and Germline variants and helps oncologist(s) to personalize treatment based on individual cancer patients' tumor genomic profiling.